Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 1998 Apr 18;316(7139):1183-4.
doi: 10.1136/bmj.316.7139.1183.

Monitoring randomised controlled trials. Parkinson's disease trial illustrates the dangers of stopping early

K R Abrams
Editorial

Monitoring randomised controlled trials. Parkinson's disease trial illustrates the dangers of stopping early

K R Abrams. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

References

    1. Ben-Shlomo Y, Churchyard A, Head J, Hurwitz B, Overstall P, Ockelford J, et al. Investigation by Parkinson’s Disease Research Group of the United Kingdom into excess mortality seen with combined levodopa and selegiline in patients with early, mild Parkinson’s disease. BMJ. 1998;316:1191–1196. - PMC - PubMed
    1. Parkinson’s Disease Research Group in the United Kingdom. Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson’s disease: three year interim report. BMJ. 1993;307:469–472. - PMC - PubMed
    1. Lees AJ.on behalf of the Parkinson’s Disease Research Group of the United Kingdom. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson’s disease BMJ 19953111602–1607. - PMC - PubMed
    1. Birkmayer W, Knoll J, Riederer P, Youdim MBH, Hars V, Marton J. Increased life expectancy resulting from addition of l-deprenyl to Madopar treatment in Parkinson’s disease: a long term study. J Neural Transm. 1985;64:113–127. - PubMed
    1. Freedman LS, Spiegelhalter DJ. The assessment of subjective opinion and its use in relation to stopping rules for clinical trials. Statistician. 1983;32:153–160.

MeSH terms